aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.889
+0.065 (7.85%)
Mar 9, 2026, 3:56 PM EDT - Market open
aTyr Pharma Employees
As of December 31, 2024, aTyr Pharma had 65 total employees, including 56 full-time and 9 part-time employees. The number of employees increased by 6 or 10.17% compared to the previous year.
Employees
65
Change (1Y)
6
Growth (1Y)
10.17%
Revenue / Employee
$2,923
Profits / Employee
-$1,140,277
Market Cap
87.14M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Pliant Therapeutics | 171 |
| Seres Therapeutics | 103 |
| PolyPid | 73 |
| Verrica Pharmaceuticals | 71 |
| PMV Pharmaceuticals | 47 |
| Pyxis Oncology | 44 |
| AN2 Therapeutics | 22 |
ATYR News
- 3 days ago - aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update - GlobeNewsWire
- 10 days ago - Ethos to Participate in The Citizens Technology Conference - GlobeNewsWire
- 11 days ago - Ethos Technologies Inc. (LIFE) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results - GlobeNewsWire
- 16 days ago - aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 19 days ago - aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026 - GlobeNewsWire
- 4 weeks ago - The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts. - Barrons